Paper22692575
Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
Leth-Larsen R and 7 others. Mol Med, 2012. Cited by 75 papers, by iCite.
Cite this record
ConductScience Library. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis. Papers, record 22692575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22692575
- Cell line
- HMT-3909S133 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
- PubMed
Connected records3
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Cell Compartmentation | Major topic |
| Gene Expression Profiling | Major topic |
| Genetic Heterogeneity | Major topic |
| Hyaluronan Receptors | Major topic |
| Neoplastic Stem Cells | Major topic |
| Animals | |
| Biomarkers, Tumor | |
| CD24 Antigen | |
| Cell Line, Tumor | |
| Cell Transformation, Neoplastic | |
| Clone Cells | |
| Drug Resistance, Neoplasm | |
| Epithelial Cells | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Mesoderm | |
| Mice | |
| Neoplasm Metastasis | |
| Neoplasm Proteins | |
| Phenotype | |
| Prognosis | |
| Proteomics | |
| Transcriptome |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18681906 | High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. | J Cell Mol Med | 2009 | https://conductscience.org/library/papers/18681906 | PubMed |
| 2 | 16049480 | Genes that mediate breast cancer metastasis to lung. | Nature | 2005 | https://conductscience.org/library/papers/16049480 | PubMed |
| 3 | 10430922 | Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10430922 | PubMed |
| 4 | 19259795 | Treatment resistance in stem cells and breast cancer. | J Mammary Gland Biol Neoplasia | 2009 | https://conductscience.org/library/papers/19259795 | PubMed |
| 5 | 16652145 | Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. | Oncogene | 2006 | https://conductscience.org/library/papers/16652145 | PubMed |
| 6 | 18559090 | The CD44+/CD24- phenotype is enriched in basal-like breast tumors. | Breast Cancer Res | 2008 | https://conductscience.org/library/papers/18559090 | PubMed |
| 7 | 19832034 | Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer. | Cancer Invest | 2009 | https://conductscience.org/library/papers/19832034 | PubMed |
| 8 | 18485877 | The epithelial-mesenchymal transition generates cells with properties of stem cells. | Cell | 2008 | https://conductscience.org/library/papers/18485877 | PubMed |
| 9 | 17062128 | CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. | Breast Cancer Res | 2006 | https://conductscience.org/library/papers/17062128 | PubMed |
| 10 | 16478745 | Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. | J Natl Cancer Inst | 2006 | https://conductscience.org/library/papers/16478745 | PubMed |
| 11 | 21305539 | Prediction of pathologic complete response to sequential paclitaxel and 5-fluorouracil/epirubicin/cyclophosphamide therapy using a 70-gene classifier for breast cancers. | Cancer | 2011 | https://conductscience.org/library/papers/21305539 | PubMed |
| 12 | 14758095 | Relevance of breast cancer cell lines as models for breast tumours: an update. | Breast Cancer Res Treat | 2004 | https://conductscience.org/library/papers/14758095 | PubMed |
| 13 | 16990388 | Cancer stem cells. | N Engl J Med | 2006 | https://conductscience.org/library/papers/16990388 | PubMed |
| 14 | 19682730 | Identification of selective inhibitors of cancer stem cells by high-throughput screening. | Cell | 2009 | https://conductscience.org/library/papers/19682730 | PubMed |
| 15 | 19341246 | Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers. | J Proteome Res | 2009 | https://conductscience.org/library/papers/19341246 | PubMed |
| 16 | 18445819 | Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. | J Natl Cancer Inst | 2008 | https://conductscience.org/library/papers/18445819 | PubMed |
| 17 | 15803154 | Tumour stem cells and drug resistance. | Nat Rev Cancer | 2005 | https://conductscience.org/library/papers/15803154 | PubMed |
| 18 | 17133114 | Cancer stem cells and oncology therapeutics. | Curr Opin Oncol | 2007 | https://conductscience.org/library/papers/17133114 | PubMed |
| 19 | 12606218 | Mass spectrometric-based approaches in quantitative proteomics. | Methods | 2003 | https://conductscience.org/library/papers/12606218 | PubMed |
| 20 | 12629218 | Prospective identification of tumorigenic breast cancer cells. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12629218 | PubMed |
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41183038 | LSR overexpression induces chemoresistance in triple negative breast cancer cells through MDR1 upregulation and apoptosis attenuation. | PLoS One | 2025 | https://conductscience.org/library/papers/41183038 | PubMed |
| 40230213 | Lineage Tracing and Single-Cell RNA Sequencing Reveal a Common Transcriptional State in Breast Cancer Tumor-Initiating Cells Characterized by IFN/STAT1 Activity. | Cancer Res | 2025 | https://conductscience.org/library/papers/40230213 | PubMed |
| 39851559 | The Multifaceted Roles of MicroRNA-181 in Stem Cell Differentiation and Cancer Stem Cell Plasticity. | Cells | 2025 | https://conductscience.org/library/papers/39851559 | PubMed |
| 39073846 | Prognostic value of blood GRHL2 in patients with non-small-cell lung cancer after radiotherapy and chemotherapy. | Biomark Med | 2024 | https://conductscience.org/library/papers/39073846 | PubMed |
| 35586495 | Lipolysis-Stimulated Lipoprotein Receptor Impairs Hepatocellular Carcinoma and Inhibits the Oncogenic Activity of YAP1 via PPPY Motif. | Front Oncol | 2022 | https://conductscience.org/library/papers/35586495 | PubMed |
| 34801088 | Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34801088 | PubMed |
| 33810548 | Novel GRHL2 Gene Variant Associated with Hearing Loss: A Case Report and Review of the Literature. | Genes (Basel) | 2021 | https://conductscience.org/library/papers/33810548 | PubMed |
| 32974388 | Spotlight on the Granules (Grainyhead-Like Proteins) - From an Evolutionary Conserved Controller of Epithelial Trait to Pioneering the Chromatin Landscape. | Front Mol Biosci | 2020 | https://conductscience.org/library/papers/32974388 | PubMed |
| 32125607 | Epithelial Plasticity, Autophagy and Metastasis: Potential Modifiers of the Crosstalk to Overcome Therapeutic Resistance. | Stem Cell Rev Rep | 2020 | https://conductscience.org/library/papers/32125607 | PubMed |
| 31305429 | Prognostic and clinicopathological significance of S100A14 expression in cancer patients: A meta-analysis. | Medicine (Baltimore) | 2019 | https://conductscience.org/library/papers/31305429 | PubMed |
| 31123345 | ZEB1 and IL-6/11-STAT3 signalling cooperate to define invasive potential of pancreatic cancer cells via differential regulation of the expression of S100 proteins. | Br J Cancer | 2019 | https://conductscience.org/library/papers/31123345 | PubMed |
| 31027259 | Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics. | Cells | 2019 | https://conductscience.org/library/papers/31027259 | PubMed |
| 30718962 | Combining data from TCGA and GEO databases and reverse transcription quantitative PCR validation to identify gene prognostic markers in lung cancer. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/30718962 | PubMed |
| 30526604 | Aggressiveness of non-EMT breast cancer cells relies on FBXO11 activity. | Mol Cancer | 2018 | https://conductscience.org/library/papers/30526604 | PubMed |
| 30505319 | Cancer Stem Cells: Emergent Nature of Tumor Emergency. | Front Genet | 2018 | https://conductscience.org/library/papers/30505319 | PubMed |
| 29733545 | Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma. | Thorac Cancer | 2018 | https://conductscience.org/library/papers/29733545 | PubMed |
| 29649984 | BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29649984 | PubMed |
| 29241971 | Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70S6K with Dendrimer Nanovector-Based siRNA Delivery. | Mol Ther | 2018 | https://conductscience.org/library/papers/29241971 | PubMed |
| 28649800 | Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness. | Mol Oncol | 2017 | https://conductscience.org/library/papers/28649800 | PubMed |
| 28278050 | Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells. | Cell Cycle | 2017 | https://conductscience.org/library/papers/28278050 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD24 | 100133941 | PubTator's text mining | https://conductscience.org/library/genes/100133941 | NCBI Gene |
| CD44 | 960 | PubTator's text mining | https://conductscience.org/library/genes/960 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| LSR | 51599 | PubTator's text mining | https://conductscience.org/library/genes/51599 | NCBI Gene |
| MUC1 | 4582 | PubTator's text mining | https://conductscience.org/library/genes/4582 | NCBI Gene |
| RAB25 | 57111 | PubTator's text mining | https://conductscience.org/library/genes/57111 | NCBI Gene |
| S100A14 | 57402 | PubTator's text mining | https://conductscience.org/library/genes/57402 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22692575
GET https://conductscience.org/api/papers/v1/22692575/references?page=2